Screening and Risk Factor Assessment of Cataract and Glaucoma in Hypertensive and Diabetic Populations along the Surabaya Coast
DOI:
https://doi.org/10.22225/ijbstm.2.2.2025.60-64Keywords:
Cataract, glaucoma, diabetes mellitus, hypertensionAbstract
Background: The coexistence of cataract, glaucoma, diabetes mellitus, and hypertension imposes a substantial ocular health burden in aging populations, especially in coastal communities exposed to ultraviolet radiation.
Methods: This observational-analytical study evaluated the influence of hypertension and diabetes mellitus on the incidence of cataract and glaucoma among residents of Kedung Cowek, Surabaya (April 2025). Direct clinical examinations, demographic and medical histories, and ocular assessments were performed on all eligible patients presenting with blurred vision and documented hypertension or diabetes (total sampling).
Results: Among 12 hypertensive patients along the Surabaya Coast, 8 (66.7%) had ocular abnormalities. Cataract was the most common finding (5 cases, 41.7%), followed by glaucoma (3 cases, 25%). Pterygium occurred in 4 cases (33.3%), likely linked to high UV exposure.
Conclusion: Diabetes, and hypertension appears to accelerate cataract and glaucoma development in this coastal population. Oxidative stress from combined metabolic and environmental factors may overwhelm ocular defenses, increasing vision-related risk.
References
Dietze, J., Blair, K., Zeppieri, M., et al. (2025). Glaucoma. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538217/.
GBD 2019 Blindness and Vision Impairment Collaborators, & Vision Loss Expert Group of the Global Burden of Disease Study. (2021). Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study. The Lancet Global Health, 9(2), e144–e160. https://doi.org/10.1016/S2214-109X(20)30489-7.
González, P., Lozano, P., Ros, G., & Solano, F. (2023). Hyperglycemia and oxidative stress: An integral, updated and critical overview of their metabolic interconnections. International Journal of Molecular Sciences, 24(11), 9352. https://doi.org/10.3390/ijms24119352.
Kiziltoprak, H., Tekin, K., Inanc, M., & Goker, Y. S. (2019). Cataract in diabetes mellitus. World Journal of Diabetes, 10(3), 140–153. https://doi.org/10.4239/wjd.v10.i3.140.
Ko, F., Boland, M. V., Gupta, P., et al. (2016). Diabetes, triglyceride levels, and other risk factors for glaucoma in the National Health and Nutrition Examination Survey 2005–2008. Investigative Ophthalmology & Visual Science, 57(4), 2152–2157. https://doi.org/10.1167/iovs.15-18373.
Li, J., Buonfiglio, F., Zeng, Y., Pfeiffer, N., & Gericke, A. (2024). Oxidative stress in cataract formation: Is there a treatment approach on the horizon? Antioxidants, 13(10), 1249. https://doi.org/10.3390/antiox13101249.
Lu, P., Chen, X., Kang, Y., Ke, L., Wei, X., & Zhang, W. (2007). Pterygium in Tibetans: A population-based study in China. Clinical & Experimental Ophthalmology, 35(8), 828–833. https://doi.org/10.1111/j.1442-9071.2007.01630.x.
Miller, K. M., Oetting, T. A., Tweeten, J. P., Carter, K., Lee, B. S., Lin, S., Nanji, A. A., Shorstein, N. H., Musch, D. C., & American Academy of Ophthalmology Preferred Practice Pattern Cataract/Anterior Segment Panel. (2022). Cataract in the adult eye preferred practice pattern. Ophthalmology, 129(1), P1–P126. https://doi.org/10.1016/j.ophtha.2021.10.006.
Puspitasari, A. Y., Akib, K. M. N. R., Maharani, R. N., Kanang, I. L. D., & Kusumawardhani, S. I. (2024). Prevalensi kejadian katarak dengan diabetes mellitus di RS Ibnu Sina Makassar tahun 2020–2022. *Fakumi Medical Journal*, 4(2). https://fmj.fk.umi.ac.id/index.php/fmj/article/download/398/276/
Pyo, E. Y., Mun, G. H., & Yoon, K. C. (2016). The prevalence and risk factors for pterygium in South Korea: The Korea National Health and Nutrition Examination Survey (KNHANES) 2009–2010. Epidemiology and Health, 38, e2016015. https://doi.org/10.4178/epih.e2016015.
Rif'Ati, L., Halim, A., Lestari, Y. D., Moeloek, N. F., & Limburg, H. (2021). Blindness and visual impairment situation in Indonesia based on Rapid Assessment of Avoidable Blindness surveys in 15 provinces. Ophthalmic Epidemiology, 28(5), 408–419. https://doi.org/10.1080/09286586.2020.1853178.
Rim, T. H., Kim, M. H., Kim, W. C., Kim, T. I., & Kim, E. K. (2014). Cataract subtype risk factors identified from the Korea National Health and Nutrition Examination Survey 2008–2010. BMC Ophthalmology, 14, 4. https://doi.org/10.1186/1471-2415-14-4.
Song, B. J., Aiello, L. P., & Pasquale, L. R. (2016). Presence and risk factors for glaucoma in patients with diabetes. Current Diabetes Reports, 16(12), 124. https://doi.org/10.1007/s11892-016-0815-6.
Syeda Khadija, T., Kaneez, F., Mobin, F., et al. (2024). Prevalence of type 2 diabetes mellitus and hypertension in cataract patients: A prospective study at a tertiary care hospital. Medtigo Journal of Medicine, 2(3), e3062248. https://doi.org/10.63096/medtigo3062248.
World Health Organization. (2002). *Global solar UV index: A practical guide*. World Health Organization. https://www.who.int/publications/i/item/9241590076
Varma, S. D., Kovtun, S., & Hegde, K. R. (2011). Role of ultraviolet irradiation and oxidative stress in cataract formation—Medical prevention by nutritional antioxidants and metabolic agonists. Eye & Contact Lens, 37(4), 233–245. https://doi.org/10.1097/ICL.0b013e31821ec4f2.
Yu, X., Lyu, D., Dong, X., He, J., & Yao, K. (2014). Hypertension and risk of cataract: A meta-analysis. PLoS ONE, 9(12), e114012. https://doi.org/10.1371/journal.pone.0114012.
Zhao, D., Cho, J., Kim, M. H., et al. (2015). Diabetes, fasting glucose, and the risk of glaucoma: A meta-analysis. Ophthalmology, 122(1), 72–78. https://doi.org/10.1016/j.ophtha.2014.07.051.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Irma Andriani Pasaribu, Aditya Wira Buana, Prawesty Diah Utami
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
